Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study

PURPOSE: The efficacy of cisplatin, irinotecan, and bevacizumab was evaluated in patients with extensive-stage small-cell lung cancer (ES-SCLC). PATIENTS AND METHODS: Patients with ES-SCLC received cisplatin 30 mg/m(2) and irinotecan 65 mg/m(2) on days 1 and 8 plus bevacizumab 15 mg/kg on day 1 ever...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ready, Neal E., Dudek, Arkadiusz Z., Pang, Herbert H., Hodgson, Lydia D., Graziano, Stephen L., Green, Mark R., Vokes, Everett E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3221525/
https://ncbi.nlm.nih.gov/pubmed/21969504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.35.6923
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados